We are live on ! Find out more
GRTS

Gritstone bio, Inc. Common Stock

Delisted

GRTS was delisted on the 21st of October, 2024.

79 hedge funds and large institutions have $24.2M invested in Gritstone bio, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 14 increasing their positions, 25 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

674% more call options, than puts

Call options by funds: $1.03M | Put options by funds: $133K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

7% less funds holding

Funds holding: 8579 (-6)

18% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 33

44% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 25

80% less capital invested

Capital invested by funds: $120M → $24.2M (-$96.2M)

Holders
79
Holders Change
-6
Holders Change %
-7.06%
% of All Funds
1.14%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
27
Increased
14
Reduced
25
Closed
33
Calls
$1.03M
Puts
$133K
Net Calls
+$897K
Net Calls Change
+$10.5M

GRTS Hedge Fund Activity: Q2 2024 in Review

79 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q2 2024, worth a combined $24.2M — down 80% from $120M a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of GRTS and 27 opened new positions — a net loss of 6 holders — while 25 trimmed existing stakes and 14 added.

The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $2.92M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $7.9M sold.

  • 79 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q2 2024, down from 85 in Q1 2024.
  • Funds reported $24.2M of Gritstone bio, Inc. Common Stock stock for Q2 2024, down 80% quarter-over-quarter.
  • 27 funds opened new Gritstone bio, Inc. Common Stock positions in Q2 2024 and 33 closed out, a net change of -6 holders.
  • The largest Gritstone bio, Inc. Common Stock buyer in Q2 2024 was Alyeska Investment Group, an estimated $2.92M added.
  • The largest Gritstone bio, Inc. Common Stock seller in Q2 2024 was Point72 Asset Management, an estimated $7.9M sold.

Based on aggregated 13F filings for Q2 2024.